Treatment of influenza with neuraminidase inhibitors: virological implications
Abstract
Evaluation of the emergence of influenza virus resistance to neuraminidase inhibitors (NAIs) is now demanded following experience with amantadinamines. Preliminary data have indicated that NAI-resistant virus is unlikely to emerge readily in the clinic and this is consistent with the difficulty expe …
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
review
animals
humans
pubmed abstract
nih
national institutes of health
national library of medicine
drug resistance
multiple
enzyme inhibitors / pharmacology
enzyme inhibitors / therapeutic use*
antiviral agents / therapeutic use*
viral*
influenza
human / drug therapy*
antiviral agents / pharmacology
influenza a virus / isolation & purification
influenza a virus / drug effects
human / virology*
guanidines
influenza b virus / drug effects
oseltamivir
pyrans
zanamivir
pmid:11779389
pmc1088566
doi:10.1098/rstb.2001.1002
n a roberts
acetamides / pharmacology
acetamides / therapeutic use
influenza a virus / genetics*
influenza b virus / genetics
influenza b virus / isolation & purification
neuraminidase / antagonists & inhibitors
sialic acids / pharmacology
sialic acids / therapeutic use
Access
Citation
ID:
269400
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
269400
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet
